Differentiation between autism and schizophrenia in the screening phase. Pilot-research.

Completed

• Conditions: autism and schizphrenia; 10012562

• Registration Number: NL-OMON32100
• Lead Sponsor: GGZ Eindhoven (Eindhoven)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

- male
- age between 18 and 65
- normal or high verbal intelligence
- diagnosis schizophrenia or high functioning autism
- a comorbid psychiatric desease may not be prominent

Exclusion Criteria

see D4a

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To test hypothesis 1 the mean sumscores per instrument, per group will be<br /><br>calculated for both versions of the VIS-V and the AQ. The mean total scores of<br /><br>the two groups for both versions of the VIS-V and the AQ will be compared to<br /><br>each other with T-tests. These tests are used to determine the equality of the<br /><br>mean scores of the two independent groups.<br /><br><br /><br>To test hypothesis 2 the meanscores of the subscales of the VIS-V and the AQ<br /><br>for both groups will be compared with T-tests. These tests are used to<br /><br>determine the equality of the mean scores of the two independent groups.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>To test hypothesis 3 the interference of negative symptomatology with the hight<br /><br>of the scores on the VIS-V and AQ questionnaire is measured with a liniair<br /><br>regressionanalysis. </p><br>